HOTEL INFORMATION

REGISTRATION FORM

2:20 pm – 4:00 pm Genitourinary Malignancy Session Moderator: Edgardo S. Santos

2:20 pm – 3:00 pm Tyrosine Kinase Inhibitors and Other Pathways in Renal Cell Carcinoma. Primo N. Lara, Jr.

3:00 pm – 3:40 pm Novel Pathways and Genomics in the Management of Prostate Cancer. Alan Koletsky

3:40 pm – 3:50 pm Round Table Discussion and Q & A Session. Speakers: Lara, Koletsky and Santos

3:50 pm – 4:00 pm Coffee Break & Visit Exhibits

4:00 pm – 5:40 pm Hematology Malignancies Session Moderator: Eduardo M. Sotomayor 4:00: pm – 4:30 pm Immunotherapy and Targeted Therapy in Multiple Myeloma. Sergio Giralt

4:30 pm – 5:00 pm Targeted Therapy for B- and T-Cell Non-Hodgkin’s Lymphomas. Eduardo M. Sotomayor

5:00 pm – 5:30 pm High Risk Myelodysplasia and Acute Leukemias. Martin Tallman

5:30 pm – 6:00 pm Round Table Discussion and Q & A Session. Speakers: Giralt, Sotomayor, Tallman

Sunday, January 22, 20177:00 am – 3:10 am Registration &Visit Exhibits

7:40 am – 8:40 am Breakfast & Learn Symposia (non CME)

8:40 am – 9:50 am Gastrointestinal Malignancy Session Moderator: Caio Max Rocha-Lima

8:40 am – 9:10 am Novel Advances in Treatment of Gastric Cancers and Pancreatobiliary Malignancies. Caio Max Rocha Lima

9:10 am – 9:40 am Genomics and New Insights of Colorectal Cancer. Jaffe Ajani

9:40 am – 9:50 am Round Table Discussion and Q & A session Speakers: Ajani and Rocha-Lima

9:50 am – 10:20 am Thyroid Malignancies. Brian Hunis

10:20 am – 10:40 am Coffee Break & Visit Exhibits

10:40 am – 12:40 pm Lung Cancer Session Moderator: Edgardo S. Santos

10:40 am – 11:10 am EGFR, ALK and ROS-1 in Lung Cancer. Luis E. Raez

11:10 am – 11:40 am Other Novel Pathways in Lung Cancer (MET, RET, NTRK, BRAF) and Antiangiogenic Agents. Barbara Gitlitz

11:40 am – 12:10 pm Where are we now in Squamous-NSCLC and Small Cell Lung Cancer? Edgardo S. Santos

12:10 pm – 12:30 pm Round Table Discussion and Q & A Session. Speakers: Gitlitz, Raez & Santos

12:30 pm – 1:40 pm Lunch & Learn Symposia

1:40 pm – 3:15 pm Breast Cancer Section Moderator: Denisse Bretel

1:40 pm – 2:20 pm Anti-HER2 Therapies in Breast Cancer: Adjuvant and Neoadjuvant. Hope Rugo 2:20 pm – 3:00 pm Chemotherapy and Hormonal Therapy in the Metastatic Setting. (non Her2 therapy) Vicente Valero

3:00 pm – 3:10 pm Round Table Discussion and Q & A Session. Speakers: Rugo, Valero, and Bretel

3:10 pm Meeting Adjourn and Closing Remarks

The Conrad Hilton Hotel Miami 1395 Brickell Avenue Miami, FL 33131 Telephone: 305-503-6585 Website: http://conradhotels1.hilton.com

Discover the luxury of the Conrad Miami, the premier hotel in South Florida, com-bining the ultimate hotel service and the latest technological advancements with the fashion sensibilities of downtown Miami. Located in the innovatively designed structure of concave glass and steel, in the heart of the city’s financial district, the Conrad Miami hotel overlooks Biscayne Bay in Florida. The Conrad Miami has quick and easy access to many attractions in downtown Miami, including South Beach, Coconut Grove and Key Biscayne and is also just 15 minutes from the Mi-ami International Airport.

The hotel is offering special rates during this conference of $315 Deluxe City View; $345 Deluxe Bay View plus tax, European plan (no meals). The cut of date to make reservations is January 4, 2017, after this date reservations are subject to hotel availability.

Make your reservations by calling 1-800-CONRADS and identify you as attending the “Miami Cancer Meeting” group code “AMC ” or using the link https://resweb.passkey.com/go/MCM2017

Meetings, Events and Conference Coordinators, Inc.P.O. Box 430376Miami, FL 33243-0376

_____________PRST STD

US Postage PAID

Miami, FLPermit No. 1429

14TH ANNUAL MIAMI CANCER MEETING (MCM):

“From Chemotherapy to Targeted Therapy, Immunotherapy and Beyond!”

January 20-22, 2017Conrad Hilton Hotel

Miami, Florida

PROGRAM AGENDA Continued...

January 20-22, 2017Conrad Hilton Hotel

Miami, Florida

14TH ANNUAL MIAMI CANCER MEETING (MCM): “From Chemotherapy to Targeted Therapy, Immunotherapy and Beyond!”

Fees: $250 - Physicians

$100 - Residents, Fellows,

Nurses & Allied

Health Professionals

$300 - Industry Professionals

Registration fee includes all day admission to the Friday evening, Saturday, and Sunday scientific presentations. Refunds must be provided in writing prior to December 20th, 2016 no Refunds will be provided. Prior to the December 20th deadline any cancella-tion will include a $50 administrative charge. Register online at www.meccinc.com

Register online at www.meccinc.com

CONFERENCE MANAGEMENT MECC (Meetings Events & Conference Coordinators, Inc.)6619 S Dixie Highway #341, Miami, FL 33143Telephone 305/663-1628 Office Fax 305/675-2718

Or visit our website at www.meccinc.com

REGISTRATION

14th Annual Miami Cancer Meeting (MCM): “From Chemotherapy to Targeted Therapy, Immunotherapy and Beyond!”

January 20-22, 2017Conrad Hilton Hotel, Miami, FL

Register online at www.meccinc.com or FAX to 305/675-2718.

Name __________________________________________________________________________ Degree __________________________

Address ___________________________________________________________________________________________________________

City _________________________________________________ State ______________________ Zip _____________________________

Telephone (_____)_____________________________________________ Fax (_____) __________________________________________

Email address _____________________________________________________________________________________________________

Specialty _________________________________________________________________________________________________________

Type of Practice: o Private o Academic o Hospital o Resident/Fellow Registration fee: $ 250 - Physicians $ 100 - Residents, Fellows, Nurses and Allied Health Professionals $ 300 - Industry Professionals

Enclosed is my check in the i/a/o of _____ for registration of this course.I authorize MECC to charge my credit card i/a/o $______ for registration of this course using the following credit card.

Name on Card ________________________________________________________________ Exp. Date ___________________________

Card number _________________________________________________________________ CVV ________________________________

Authorized signer __________________________________________________________________________________________________

If you require special assistance or have specific dietary requirements, please contact MECC, Inc. no later than January 4th, 2017 via email at tvalls@meccinc.com.

Sponsored by:The Medical Educator Consortium

Jumana Ashy, M.S, Pharm.DEileen Butler, RN, MSN. OCN, CPHON, BMTCNGerardo Colon-Otero, MD Dina Dumercy, Pharm.D., BCOP

Primo Lara, M.D.Jessica MacIntrye, ARNP, NP-CEduardo Sotomayor, MD

Educational Committee

Luis E. Raez, M.D, FACP, FCCPChief of Hematology-Oncology & Medical DirectorMemorial Cancer InstituteMemorial Health Care SystemClinical Associate Professor of MedicineHerbert Wertheim College of MedicineFlorida International UniversityMiami, Florida

Caio Max S. Rocha Lima, M.D. Hematology and OncologyAssociate Cancer Center Director for Translational Research Gibbs Cancer Center & Research InstituteCMO Guardian Research Network Spartanburg Healthcare System Spartanburg, SC

Edgardo S. Santos Castillero, M.D., FACPMedical Director of Cancer ResearchThoracic and Head and Neck Cancer ProgramsEugene & Christine Lynn Cancer InstituteAssociate Professor of Clinical Biomedical ScienceCharles E. Schmidt College of MedicineFlorida Atlantic UniversityBoca Raton, FL

Program Directors

Co-Sponsored by:Florida Society of Clinical Oncology

Friday, January 20, 2017:5:00 pm – 7:30 pm Registration & Visit Exhibits

5:30 pm – 5:40 pm Welcome and Introduction Luis E. Raez

5:40 pm – 7:50 pm Supportive Care and Palliative Therapy Session Moderator: Dina Dumercy . 5:40 pm – 6:10 pm Management of Immunotherapy-Induced Disorders (pneumonitis, colitis, thyroid disorders, skin rash, and others). Adrienne Vazquez

6:10 pm – 6:40 pm Cancer Therapy-Induced Bone Loss and Malignant Hypercalcemia. Eriberto Marques, Jr.

6:40 pm – 7:10 pm Nausea and Vomiting: Novel advances in Emesis Management. Jessica MacIntyre 7:10 pm – 7:40 pm Keynote Speaker: The Evolution of Lung Cancer Therapy in the Last Decade: “From Chemotherapy to Targeted Therapy, Christian Rolfo Immunotherapy and Beyond!”

7:40 pm – 7:50 pm Round Table Discussion and Q & A Session. Speakers: MacIntyre, Vazquez, Marques, and Rolfo.

8:00 pm – 9:00 pm Dinner & Learn Symposia (non CME)

Saturday, January 21, 20177:00 am – 6:00 pm Registration & Visit Exhibits

7:40 am – 8:40 am Breakfast & Learn Symposium (non CME)

8:40 am – 10:40 am Immunotherapy Session 1 Malignant Diseases: The New Targets of Immunotherapy. Moderator: Luis E. Raez

8:40 am – 9:20 am Immunotherapy in Lung Cancer. Scott Antonia 09:10 am – 9:20 am – 10:00 am Immunotherapy in Genitourinary Cancers. Alan Koletsky

10:00 am – 10:40 am Immunotherapy in Melanoma. Jose Lutzky

10:40 am – 11:00 am Coffee Break & Visit Exhibits

11:00 am – 1:00 am Immunotherapy Session 2 Malignant Diseases: The New Targets of Immunotherapy. Moderator: Brian Hunis

11:00 am – 11:40 pm Immunotherapy in Head and Neck Cancer. Edgardo S. Santos

11:40 am – 12:20 pm Immunotherapy in Breast and Gynecologic Malignancies. Gerardo Colon-Otero 12:20 pm – 12:50 pm Is it PDL-1 the Biomarker? Mutation Burden? Or What is the Best Biomarker for Lung Cancer Immunotherapy? Taofek Owonikoko

12:50 pm – 1:00 pm Round Table Discussion and Q & A Session. Speakers: Santos, Colon-Otero, Owonikoko and Hunis1:00 pm – 2:00 pm Lunch & Learn Symposia (non-CME)

2:00 pm – 2:20 pm Coffee Break and Visit Exhibits

Educational CommitteeJumana Ashy, M.S, Pharm.DEileen Butler, RN, MSN. OCN, CPHON, BMTCNGerardo Colon-Otero, MD Dina Dumercy, Pharm.D., BCOPPrimo Lara, M.D.Jessica MacIntrye, ARNP, NP-CEduardo Sotomayor, MD

Distinguished FacultyJaffer A. Ajani, M.D.Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, Professor, Department of Epidemiology, Division of OVP, Cancer Prevention and Population SciencesThe University of Texas MD Anderson Cancer CenterHouston, TX

Scott J. Antonia, M.D., Ph.D.Department Chair of the Thoracic Oncology Department H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. Professor of Oncologic SciencesUniversity of South Florida College of MedicineTampa, FL

Jumana Ashy, M.S, Pharm.DClinical PharmacistPediatric Hematology-Oncology Clinic and Infusion Center University of Miami, Miller School of MedicineMiami, FL

Denisse Bretel, MDMedical Director,GECO (Peruvian Oncology Research Group)Lima, Peru

Eileen Bulter, RN, MSN. OCN, CPHON, BMTCN University of Miami Miller School of MedicineMiami, FL

Gerardo Colon-Otero, M.D.Associate Professor of MedicineMayo Clinic College of MedicineMayo Clinic, Jacksonville, FL

Dina Dumercy, Pharm.D.,BCOPClinical Coordinator OncologyMemorial Cancer InstitutePharmacy DepartmentMemorial Healthcare SystemHollywood, FL

Barbara J. Gilitz, M.D.Associate Professor of Medicine,USC Keck School of MedicineLos Angeles, CA

Sergio A. Giralt, M.D.Chief, Adult Bone Marrow Transplant Service; Melvin Berlin Family Chair in Multiple MyelomaMemorial Sloan Kettering Cancer CenterNew York, NY

Brian Hunis, M.D.Director of Head & Neck Cancer and QualityMemorial Cancer InstituteClinical Associate Professor of MedicineHerbert Wertheim College of MedicineFlorida International UniversityHollywood, FL

Alan Koletsky, M.D.Affiliate Assistant Professor of Clinical Biomedical ScienceCharles E. Schmidt College of MedicineFlorida Atlantic UniversityGenitourinary Cancer Research ProgramLynn Cancer InstituteBoca Raton, FL

Primo N. Lara, Jr., M.D.Professor of Medicine, UC Davis School of MedicineActing Director, UC Davis Comprehensive Cancer CenterSacramento CA

Jose Lutzky, M.D.Co-Chief, Hematology & OncologyDirector, Mount Sinai Melanoma ProgramMount Sinai Medical Center Miami, FL

Jessica MacIntyre, ARNP, NP-CSylvester Comprehensive Cancer CenterUniversity of Miami Miller School of MedicineMiami, FL

Eriberto Marques Jr., M.D.Medical Director of Santa Agueda HospitalDepartment of Medical OncologyMember of SBOC/SLACOMRecife-PE, Brazil

Taofeek K Owonikoko, M.D., Ph.D.Director, Thoracic Oncology ProgramAssistant ProfessorEmory School of MedicineAtlanta, GA

Luis E. Raez, M.D, FACP, FCCPChief of Hematology-Oncology &Medical Director Memorial Cancer InstituteMemorial Health Care SystemClinical Associate Professor of MedicineHerbert Wertheim College of MedicineFlorida International UniversityMiami, Florida

Caio Max S. Rocha Lima, M.D. Hematology and OncologyAssociate Cancer Center Director for Translational Research Gibbs Cancer Center & Research InstituteCMO Guardian Research Network Spartanburg Healthcare System Spartanburg, SC

Christian Rolfo Cervetto, M.D., PhDHead of Unit Phase I - Early Clinical TrialsDirector of Clinical Trial Management ProgramOncology Department University Hospital Antwerp, Belgium

Hope Rugo, M.D.Professor of Medicine Director, Breast Oncology and Clinical Trials Education University of California San FranciscoHelen Diller Family Comprehensive Cancer CenterSan Francisco, CA

Edgardo S. Santos Castillero, M.D., FACPMedical Director of Cancer ResearchLynn Cancer Institute Thoracic and Head and Neck Cancer ProgramsAssociate Professor of Clinical Biomedical SciencesFlorida Atlantic UniversityBoca Raton, Florida

Eduardo Sotomayor, M.D.Director, George Washington University Cancer Center Professor of Medicine, George WashingtonUniversity School of Medicine & Health SciencesWashington, DC

Martin S. Tallman M.D.Chief of Leukemia ServiceMemorial Sloan Kettering Cancer CenterNew York, NY

Vicente Valero, M.D.Professor, and Deputy Chairman, Breast Medical Oncology DepartmentClinical Director, The Morgan Welch Inflammatory Breast Cancer Research Program and ClinicAssociate Director, Nellie B. Connally Breast CenterThe University of Texas M. D. Anderson Cancer CenterHouston, TX

Adrienne M. Vazquez, MSN, ACNP-BC, AOCNMemorial Sloan Kettering Cancer CenterNew York, NY

CONFERENCE DESCRIPTION

This is a three-day conference designed for medical oncologists, hematologists, radiation oncologists, surgical oncologists, physician assistants (PA), advanced registered nurse practitioners (ARNP), oncology nurses, registered pharmacists, pharmacy technicians, and radiation therapists. General practitioners (internal medicine and family medicine) will have the benefit of review standard of care and new developments in cancer management. Residents in training and fellows from these specialties are encouraged to attend.

This year, a depth discussion in immunotherapy for multiple tumor types will take place. Immunotherapy in Oncology is changing the landscape of therapy for different solid tumors such as lung cancer, bladder, kidney, melanoma, and others. Also, topics in solid tumors and hematological malignancies such as breast cancer, lung cancer, gastrointestinal (GI) malignancies, genitourinary (GU) cancers, gynecologic malignancies, head and neck cancers, melanoma, multiple myeloma, CLL and non-Hodgkin’s lymphoma, and myelodysplastic syndrome will be reviewed. There will also be a special session devoted to the area of supportive care in oncology, with emphasis on bone metastasis, malignant hypercalcemia, and management of chemotherapy, targeted therapy and immunotherapy-related side effects. The areas of focus for this conference will include the current standards of care in the treatment of all aforementioned malignancies and new developments in these areas of cancer care. There will be much emphasis on molecular diagnosis and individualization of cancer therapy based on molecular profiles. There will be reviews of new chemotherapeutic agents, new antiangiogenic agents and new immunotherapeutic agents.

Presentations from latest national (AACR 2016, ASCO 2016 and ASH 2016) and international forums (ESMO 2016 and WCLC 2016) meetings will be discussed and guidelines of cancer care will be emphasized. The participants in the meeting will have the opportunity not only to learn, review, and understand the state-of-the-art management in cancer care but also engage in personal interaction with our panel of experts in these subjects during our question and answer sessions.

CONFERENCE OBJECTIVES Upon completion of this course attendees will be able to:

1) Understand the latest advances in chemotherapy, targeted therapy and immunotherapy options available for lung cancer, breast cancer, GI malignancies, GU malignancies, melanoma, brain tumors, head and neck cancer as well as hematological malignancies including multiple myeloma, NHL, MDS, and CLL.

2) Evaluate the current standards of care in the treatment of a variety of solid and hematologic malignancies.

3) Discuss risks and benefits when combined modality of treatment (that includes radiation therapy and surgery) is delivered to patients who have localized malignant processes

(i.e., NSCLC, head and neck, prostate cancer, and others).

4) Management of adverse events from the use of novel immunotherapy and targeted therapy agents.

5) Management of complications and symptoms induced by chemotherapy, immunotherapy or targeted therapy including nausea, vomiting, hematologic toxicities (e.g., anemia, neutropenia) and others.

ACCREDITATIONThe Medical Educator Consortium is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT HOURS (CME)The Medical Educator Consortium, designates this live activity for a maximum of 15.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NURSING CEUContinuing Education Credit for Nurses will be awarded by the University of Miami Nursing Education Department. A total of 15 CEU’s will be awarded for attendance to all three days of the conference. Participants may attend separately on Friday for 2.1 credit hours, Saturday for 8.4 credit hours, and Sunday 4.5. A certificate of completion will be provided to each participant at the end of the conference. Credit will be entered into CE Broker.

PHARMACY CEUThis activity is approved for a total of 15 contact hours of Continuing Education Credit for Pharmacists and Pharmacy Technicians awarded by the University of Miami Sylvester Comprehensive Cancer Center. Participants must attend all day lectures to receive credit for that day. Partial credits are not available. Where credits are approved on a session-by-session basis, participants must attend each session in its entirety to receive complete credit for the session.. A certificate of completion will be provided to each participant at the end of the conference. Credit will be entered into CE Broker. UMHC/Sylvester is a approved by the Florida Board of Pharmacy as a provider of continuing pharmacy education. “Partial Credit are available”.

FACULTY DISCLOSURE STATEMENTThe Medical Educator Consortium (MEC) adheres to the ACCME Standards for Commercial Support. All persons that will be in a position to control the content of the CME Activity are required to disclose all relevant financial relationships. Faculty disclosure forms outlining this information will be made available to all participants prior to educational activity. MEC has also implemented a mechanism to identify and resolve all conflicts of interest prior to the education activity being delivered to learners. The source of all support from commercial interests will also be disclosed to learners prior to the beginning of the educational activity.

Educational Committee • Distinguished Faculty 13th Annual Miami Cancer Meeting (MCM): “New Horizons in Treating Patients with Cancer: The Saga of Personalized Medicine”

PROGRAM AGENDA

14th Annual Miami Cancer Meeting (MCM): “New “From Chemotherapy to Targeted Therapy,

Immunotherapy and Beyond!”

Friday, January 20, 2017:5:00 pm – 7:30 pm Registration & Visit Exhibits

5:30 pm – 5:40 pm Welcome and Introduction Luis E. Raez

5:40 pm – 7:50 pm Supportive Care and Palliative Therapy Session Moderator: Dina Dumercy . 5:40 pm – 6:10 pm Management of Immunotherapy-Induced Disorders (pneumonitis, colitis, thyroid disorders, skin rash, and others). Adrienne Vazquez

6:10 pm – 6:40 pm Cancer Therapy-Induced Bone Loss and Malignant Hypercalcemia. Eriberto Marques, Jr.

6:40 pm – 7:10 pm Nausea and Vomiting: Novel advances in Emesis Management. Jessica MacIntyre 7:10 pm – 7:40 pm Keynote Speaker: The Evolution of Lung Cancer Therapy in the Last Decade: “From Chemotherapy to Targeted Therapy, Christian Rolfo Immunotherapy and Beyond!”

7:40 pm – 7:50 pm Round Table Discussion and Q & A Session. Speakers: MacIntyre, Vazquez, Marques, and Rolfo.

8:00 pm – 9:00 pm Dinner & Learn Symposia (non CME)

Saturday, January 21, 20177:00 am – 6:00 pm Registration & Visit Exhibits

7:40 am – 8:40 am Breakfast & Learn Symposium (non CME)

8:40 am – 10:40 am Immunotherapy Session 1 Malignant Diseases: The New Targets of Immunotherapy. Moderator: Luis E. Raez

8:40 am – 9:20 am Immunotherapy in Lung Cancer. Scott Antonia 09:10 am – 9:20 am – 10:00 am Immunotherapy in Genitourinary Cancers. Alan Koletsky

10:00 am – 10:40 am Immunotherapy in Melanoma. Jose Lutzky

10:40 am – 11:00 am Coffee Break & Visit Exhibits

11:00 am – 1:00 am Immunotherapy Session 2 Malignant Diseases: The New Targets of Immunotherapy. Moderator: Brian Hunis

11:00 am – 11:40 pm Immunotherapy in Head and Neck Cancer. Edgardo S. Santos

11:40 am – 12:20 pm Immunotherapy in Breast and Gynecologic Malignancies. Gerardo Colon-Otero 12:20 pm – 12:50 pm Is it PDL-1 the Biomarker? Mutation Burden? Or What is the Best Biomarker for Lung Cancer Immunotherapy? Taofek Owonikoko

12:50 pm – 1:00 pm Round Table Discussion and Q & A Session. Speakers: Santos, Colon-Otero, Owonikoko and Hunis1:00 pm – 2:00 pm Lunch & Learn Symposia (non-CME)

2:00 pm – 2:20 pm Coffee Break and Visit Exhibits

Educational CommitteeJumana Ashy, M.S, Pharm.DEileen Butler, RN, MSN. OCN, CPHON, BMTCNGerardo Colon-Otero, MD Dina Dumercy, Pharm.D., BCOPPrimo Lara, M.D.Jessica MacIntrye, ARNP, NP-CEduardo Sotomayor, MD

Distinguished FacultyJaffer A. Ajani, M.D.Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, Professor, Department of Epidemiology, Division of OVP, Cancer Prevention and Population SciencesThe University of Texas MD Anderson Cancer CenterHouston, TX

Scott J. Antonia, M.D., Ph.D.Department Chair of the Thoracic Oncology Department H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. Professor of Oncologic SciencesUniversity of South Florida College of MedicineTampa, FL

Jumana Ashy, M.S, Pharm.DClinical PharmacistPediatric Hematology-Oncology Clinic and Infusion Center University of Miami, Miller School of MedicineMiami, FL

Denisse Bretel, MDMedical Director,GECO (Peruvian Oncology Research Group)Lima, Peru

Eileen Bulter, RN, MSN. OCN, CPHON, BMTCN University of Miami Miller School of MedicineMiami, FL

Gerardo Colon-Otero, M.D.Associate Professor of MedicineMayo Clinic College of MedicineMayo Clinic, Jacksonville, FL

Dina Dumercy, Pharm.D.,BCOPClinical Coordinator OncologyMemorial Cancer InstitutePharmacy DepartmentMemorial Healthcare SystemHollywood, FL

Barbara J. Gilitz, M.D.Associate Professor of Medicine,USC Keck School of MedicineLos Angeles, CA

Sergio A. Giralt, M.D.Chief, Adult Bone Marrow Transplant Service; Melvin Berlin Family Chair in Multiple MyelomaMemorial Sloan Kettering Cancer CenterNew York, NY

Brian Hunis, M.D.Director of Head & Neck Cancer and QualityMemorial Cancer InstituteClinical Associate Professor of MedicineHerbert Wertheim College of MedicineFlorida International UniversityHollywood, FL

Alan Koletsky, M.D.Affiliate Assistant Professor of Clinical Biomedical ScienceCharles E. Schmidt College of MedicineFlorida Atlantic UniversityGenitourinary Cancer Research ProgramLynn Cancer InstituteBoca Raton, FL

Primo N. Lara, Jr., M.D.Professor of Medicine, UC Davis School of MedicineActing Director, UC Davis Comprehensive Cancer CenterSacramento CA

Jose Lutzky, M.D.Co-Chief, Hematology & OncologyDirector, Mount Sinai Melanoma ProgramMount Sinai Medical Center Miami, FL

Jessica MacIntyre, ARNP, NP-CSylvester Comprehensive Cancer CenterUniversity of Miami Miller School of MedicineMiami, FL

Eriberto Marques Jr., M.D.Medical Director of Santa Agueda HospitalDepartment of Medical OncologyMember of SBOC/SLACOMRecife-PE, Brazil

Taofeek K Owonikoko, M.D., Ph.D.Director, Thoracic Oncology ProgramAssistant ProfessorEmory School of MedicineAtlanta, GA

Luis E. Raez, M.D, FACP, FCCPChief of Hematology-Oncology &Medical Director Memorial Cancer InstituteMemorial Health Care SystemClinical Associate Professor of MedicineHerbert Wertheim College of MedicineFlorida International UniversityMiami, Florida

Caio Max S. Rocha Lima, M.D. Hematology and OncologyAssociate Cancer Center Director for Translational Research Gibbs Cancer Center & Research InstituteCMO Guardian Research Network Spartanburg Healthcare System Spartanburg, SC

Christian Rolfo Cervetto, M.D., PhDHead of Unit Phase I - Early Clinical TrialsDirector of Clinical Trial Management ProgramOncology Department University Hospital Antwerp, Belgium

Hope Rugo, M.D.Professor of Medicine Director, Breast Oncology and Clinical Trials Education University of California San FranciscoHelen Diller Family Comprehensive Cancer CenterSan Francisco, CA

Edgardo S. Santos Castillero, M.D., FACPMedical Director of Cancer ResearchLynn Cancer Institute Thoracic and Head and Neck Cancer ProgramsAssociate Professor of Clinical Biomedical SciencesFlorida Atlantic UniversityBoca Raton, Florida

Eduardo Sotomayor, M.D.Director, George Washington University Cancer Center Professor of Medicine, George WashingtonUniversity School of Medicine & Health SciencesWashington, DC

Martin S. Tallman M.D.Chief of Leukemia ServiceMemorial Sloan Kettering Cancer CenterNew York, NY

Vicente Valero, M.D.Professor, and Deputy Chairman, Breast Medical Oncology DepartmentClinical Director, The Morgan Welch Inflammatory Breast Cancer Research Program and ClinicAssociate Director, Nellie B. Connally Breast CenterThe University of Texas M. D. Anderson Cancer CenterHouston, TX

Adrienne M. Vazquez, MSN, ACNP-BC, AOCNMemorial Sloan Kettering Cancer CenterNew York, NY

CONFERENCE DESCRIPTION

This is a three-day conference designed for medical oncologists, hematologists, radiation oncologists, surgical oncologists, physician assistants (PA), advanced registered nurse practitioners (ARNP), oncology nurses, registered pharmacists, pharmacy technicians, and radiation therapists. General practitioners (internal medicine and family medicine) will have the benefit of review standard of care and new developments in cancer management. Residents in training and fellows from these specialties are encouraged to attend.

This year, a depth discussion in immunotherapy for multiple tumor types will take place. Immunotherapy in Oncology is changing the landscape of therapy for different solid tumors such as lung cancer, bladder, kidney, melanoma, and others. Also, topics in solid tumors and hematological malignancies such as breast cancer, lung cancer, gastrointestinal (GI) malignancies, genitourinary (GU) cancers, gynecologic malignancies, head and neck cancers, melanoma, multiple myeloma, CLL and non-Hodgkin’s lymphoma, and myelodysplastic syndrome will be reviewed. There will also be a special session devoted to the area of supportive care in oncology, with emphasis on bone metastasis, malignant hypercalcemia, and management of chemotherapy, targeted therapy and immunotherapy-related side effects. The areas of focus for this conference will include the current standards of care in the treatment of all aforementioned malignancies and new developments in these areas of cancer care. There will be much emphasis on molecular diagnosis and individualization of cancer therapy based on molecular profiles. There will be reviews of new chemotherapeutic agents, new antiangiogenic agents and new immunotherapeutic agents.

Presentations from latest national (AACR 2016, ASCO 2016 and ASH 2016) and international forums (ESMO 2016 and WCLC 2016) meetings will be discussed and guidelines of cancer care will be emphasized. The participants in the meeting will have the opportunity not only to learn, review, and understand the state-of-the-art management in cancer care but also engage in personal interaction with our panel of experts in these subjects during our question and answer sessions.

CONFERENCE OBJECTIVES Upon completion of this course attendees will be able to:

1) Understand the latest advances in chemotherapy, targeted therapy and immunotherapy options available for lung cancer, breast cancer, GI malignancies, GU malignancies, melanoma, brain tumors, head and neck cancer as well as hematological malignancies including multiple myeloma, NHL, MDS, and CLL.

2) Evaluate the current standards of care in the treatment of a variety of solid and hematologic malignancies.

3) Discuss risks and benefits when combined modality of treatment (that includes radiation therapy and surgery) is delivered to patients who have localized malignant processes

(i.e., NSCLC, head and neck, prostate cancer, and others).

4) Management of adverse events from the use of novel immunotherapy and targeted therapy agents.

5) Management of complications and symptoms induced by chemotherapy, immunotherapy or targeted therapy including nausea, vomiting, hematologic toxicities (e.g., anemia, neutropenia) and others.

ACCREDITATIONThe Medical Educator Consortium is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT HOURS (CME)The Medical Educator Consortium, designates this live activity for a maximum of 15.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NURSING CEUContinuing Education Credit for Nurses will be awarded by the University of Miami Nursing Education Department. A total of 15 CEU’s will be awarded for attendance to all three days of the conference. Participants may attend separately on Friday for 2.1 credit hours, Saturday for 8.4 credit hours, and Sunday 4.5. A certificate of completion will be provided to each participant at the end of the conference. Credit will be entered into CE Broker.

PHARMACY CEUThis activity is approved for a total of 15 contact hours of Continuing Education Credit for Pharmacists and Pharmacy Technicians awarded by the University of Miami Sylvester Comprehensive Cancer Center. Participants must attend all day lectures to receive credit for that day. Partial credits are not available. Where credits are approved on a session-by-session basis, participants must attend each session in its entirety to receive complete credit for the session.. A certificate of completion will be provided to each participant at the end of the conference. Credit will be entered into CE Broker. UMHC/Sylvester is a approved by the Florida Board of Pharmacy as a provider of continuing pharmacy education. “Partial Credit are available”.

FACULTY DISCLOSURE STATEMENTThe Medical Educator Consortium (MEC) adheres to the ACCME Standards for Commercial Support. All persons that will be in a position to control the content of the CME Activity are required to disclose all relevant financial relationships. Faculty disclosure forms outlining this information will be made available to all participants prior to educational activity. MEC has also implemented a mechanism to identify and resolve all conflicts of interest prior to the education activity being delivered to learners. The source of all support from commercial interests will also be disclosed to learners prior to the beginning of the educational activity.

Educational Committee • Distinguished Faculty 13th Annual Miami Cancer Meeting (MCM): “New Horizons in Treating Patients with Cancer: The Saga of Personalized Medicine”

PROGRAM AGENDA

14th Annual Miami Cancer Meeting (MCM): “New “From Chemotherapy to Targeted Therapy,

Immunotherapy and Beyond!”

Friday, January 20, 2017:5:00 pm – 7:30 pm Registration & Visit Exhibits

5:30 pm – 5:40 pm Welcome and Introduction Luis E. Raez

5:40 pm – 7:50 pm Supportive Care and Palliative Therapy Session Moderator: Dina Dumercy . 5:40 pm – 6:10 pm Management of Immunotherapy-Induced Disorders (pneumonitis, colitis, thyroid disorders, skin rash, and others). Adrienne Vazquez

6:10 pm – 6:40 pm Cancer Therapy-Induced Bone Loss and Malignant Hypercalcemia. Eriberto Marques, Jr.

6:40 pm – 7:10 pm Nausea and Vomiting: Novel advances in Emesis Management. Jessica MacIntyre 7:10 pm – 7:40 pm Keynote Speaker: The Evolution of Lung Cancer Therapy in the Last Decade: “From Chemotherapy to Targeted Therapy, Christian Rolfo Immunotherapy and Beyond!”

7:40 pm – 7:50 pm Round Table Discussion and Q & A Session. Speakers: MacIntyre, Vazquez, Marques, and Rolfo.

8:00 pm – 9:00 pm Dinner & Learn Symposia (non CME)

Saturday, January 21, 20177:00 am – 6:00 pm Registration & Visit Exhibits

7:40 am – 8:40 am Breakfast & Learn Symposium (non CME)

8:40 am – 10:40 am Immunotherapy Session 1 Malignant Diseases: The New Targets of Immunotherapy. Moderator: Luis E. Raez

8:40 am – 9:20 am Immunotherapy in Lung Cancer. Scott Antonia 09:10 am – 9:20 am – 10:00 am Immunotherapy in Genitourinary Cancers. Alan Koletsky

10:00 am – 10:40 am Immunotherapy in Melanoma. Jose Lutzky

10:40 am – 11:00 am Coffee Break & Visit Exhibits

11:00 am – 1:00 am Immunotherapy Session 2 Malignant Diseases: The New Targets of Immunotherapy. Moderator: Brian Hunis

11:00 am – 11:40 pm Immunotherapy in Head and Neck Cancer. Edgardo S. Santos

11:40 am – 12:20 pm Immunotherapy in Breast and Gynecologic Malignancies. Gerardo Colon-Otero 12:20 pm – 12:50 pm Is it PDL-1 the Biomarker? Mutation Burden? Or What is the Best Biomarker for Lung Cancer Immunotherapy? Taofek Owonikoko

12:50 pm – 1:00 pm Round Table Discussion and Q & A Session. Speakers: Santos, Colon-Otero, Owonikoko and Hunis1:00 pm – 2:00 pm Lunch & Learn Symposia (non-CME)

2:00 pm – 2:20 pm Coffee Break and Visit Exhibits

Educational CommitteeJumana Ashy, M.S, Pharm.DEileen Butler, RN, MSN. OCN, CPHON, BMTCNGerardo Colon-Otero, MD Dina Dumercy, Pharm.D., BCOPPrimo Lara, M.D.Jessica MacIntrye, ARNP, NP-CEduardo Sotomayor, MD

Distinguished FacultyJaffer A. Ajani, M.D.Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, Professor, Department of Epidemiology, Division of OVP, Cancer Prevention and Population SciencesThe University of Texas MD Anderson Cancer CenterHouston, TX

Scott J. Antonia, M.D., Ph.D.Department Chair of the Thoracic Oncology Department H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. Professor of Oncologic SciencesUniversity of South Florida College of MedicineTampa, FL

Jumana Ashy, M.S, Pharm.DClinical PharmacistPediatric Hematology-Oncology Clinic and Infusion Center University of Miami, Miller School of MedicineMiami, FL

Denisse Bretel, MDMedical Director,GECO (Peruvian Oncology Research Group)Lima, Peru

Eileen Bulter, RN, MSN. OCN, CPHON, BMTCN University of Miami Miller School of MedicineMiami, FL

Gerardo Colon-Otero, M.D.Associate Professor of MedicineMayo Clinic College of MedicineMayo Clinic, Jacksonville, FL

Dina Dumercy, Pharm.D.,BCOPClinical Coordinator OncologyMemorial Cancer InstitutePharmacy DepartmentMemorial Healthcare SystemHollywood, FL

Barbara J. Gilitz, M.D.Associate Professor of Medicine,USC Keck School of MedicineLos Angeles, CA

Sergio A. Giralt, M.D.Chief, Adult Bone Marrow Transplant Service; Melvin Berlin Family Chair in Multiple MyelomaMemorial Sloan Kettering Cancer CenterNew York, NY

Brian Hunis, M.D.Director of Head & Neck Cancer and QualityMemorial Cancer InstituteClinical Associate Professor of MedicineHerbert Wertheim College of MedicineFlorida International UniversityHollywood, FL

Alan Koletsky, M.D.Affiliate Assistant Professor of Clinical Biomedical ScienceCharles E. Schmidt College of MedicineFlorida Atlantic UniversityGenitourinary Cancer Research ProgramLynn Cancer InstituteBoca Raton, FL

Primo N. Lara, Jr., M.D.Professor of Medicine, UC Davis School of MedicineActing Director, UC Davis Comprehensive Cancer CenterSacramento CA

Jose Lutzky, M.D.Co-Chief, Hematology & OncologyDirector, Mount Sinai Melanoma ProgramMount Sinai Medical Center Miami, FL

Jessica MacIntyre, ARNP, NP-CSylvester Comprehensive Cancer CenterUniversity of Miami Miller School of MedicineMiami, FL

Eriberto Marques Jr., M.D.Medical Director of Santa Agueda HospitalDepartment of Medical OncologyMember of SBOC/SLACOMRecife-PE, Brazil

Taofeek K Owonikoko, M.D., Ph.D.Director, Thoracic Oncology ProgramAssistant ProfessorEmory School of MedicineAtlanta, GA

Luis E. Raez, M.D, FACP, FCCPChief of Hematology-Oncology &Medical Director Memorial Cancer InstituteMemorial Health Care SystemClinical Associate Professor of MedicineHerbert Wertheim College of MedicineFlorida International UniversityMiami, Florida

Caio Max S. Rocha Lima, M.D. Hematology and OncologyAssociate Cancer Center Director for Translational Research Gibbs Cancer Center & Research InstituteCMO Guardian Research Network Spartanburg Healthcare System Spartanburg, SC

Christian Rolfo Cervetto, M.D., PhDHead of Unit Phase I - Early Clinical TrialsDirector of Clinical Trial Management ProgramOncology Department University Hospital Antwerp, Belgium

Hope Rugo, M.D.Professor of Medicine Director, Breast Oncology and Clinical Trials Education University of California San FranciscoHelen Diller Family Comprehensive Cancer CenterSan Francisco, CA

Edgardo S. Santos Castillero, M.D., FACPMedical Director of Cancer ResearchLynn Cancer Institute Thoracic and Head and Neck Cancer ProgramsAssociate Professor of Clinical Biomedical SciencesFlorida Atlantic UniversityBoca Raton, Florida

Eduardo Sotomayor, M.D.Director, George Washington University Cancer Center Professor of Medicine, George WashingtonUniversity School of Medicine & Health SciencesWashington, DC

Martin S. Tallman M.D.Chief of Leukemia ServiceMemorial Sloan Kettering Cancer CenterNew York, NY

Vicente Valero, M.D.Professor, and Deputy Chairman, Breast Medical Oncology DepartmentClinical Director, The Morgan Welch Inflammatory Breast Cancer Research Program and ClinicAssociate Director, Nellie B. Connally Breast CenterThe University of Texas M. D. Anderson Cancer CenterHouston, TX

Adrienne M. Vazquez, MSN, ACNP-BC, AOCNMemorial Sloan Kettering Cancer CenterNew York, NY

CONFERENCE DESCRIPTION

This is a three-day conference designed for medical oncologists, hematologists, radiation oncologists, surgical oncologists, physician assistants (PA), advanced registered nurse practitioners (ARNP), oncology nurses, registered pharmacists, pharmacy technicians, and radiation therapists. General practitioners (internal medicine and family medicine) will have the benefit of review standard of care and new developments in cancer management. Residents in training and fellows from these specialties are encouraged to attend.

This year, a depth discussion in immunotherapy for multiple tumor types will take place. Immunotherapy in Oncology is changing the landscape of therapy for different solid tumors such as lung cancer, bladder, kidney, melanoma, and others. Also, topics in solid tumors and hematological malignancies such as breast cancer, lung cancer, gastrointestinal (GI) malignancies, genitourinary (GU) cancers, gynecologic malignancies, head and neck cancers, melanoma, multiple myeloma, CLL and non-Hodgkin’s lymphoma, and myelodysplastic syndrome will be reviewed. There will also be a special session devoted to the area of supportive care in oncology, with emphasis on bone metastasis, malignant hypercalcemia, and management of chemotherapy, targeted therapy and immunotherapy-related side effects. The areas of focus for this conference will include the current standards of care in the treatment of all aforementioned malignancies and new developments in these areas of cancer care. There will be much emphasis on molecular diagnosis and individualization of cancer therapy based on molecular profiles. There will be reviews of new chemotherapeutic agents, new antiangiogenic agents and new immunotherapeutic agents.

Presentations from latest national (AACR 2016, ASCO 2016 and ASH 2016) and international forums (ESMO 2016 and WCLC 2016) meetings will be discussed and guidelines of cancer care will be emphasized. The participants in the meeting will have the opportunity not only to learn, review, and understand the state-of-the-art management in cancer care but also engage in personal interaction with our panel of experts in these subjects during our question and answer sessions.

CONFERENCE OBJECTIVES Upon completion of this course attendees will be able to:

1) Understand the latest advances in chemotherapy, targeted therapy and immunotherapy options available for lung cancer, breast cancer, GI malignancies, GU malignancies, melanoma, brain tumors, head and neck cancer as well as hematological malignancies including multiple myeloma, NHL, MDS, and CLL.

2) Evaluate the current standards of care in the treatment of a variety of solid and hematologic malignancies.

3) Discuss risks and benefits when combined modality of treatment (that includes radiation therapy and surgery) is delivered to patients who have localized malignant processes

(i.e., NSCLC, head and neck, prostate cancer, and others).

4) Management of adverse events from the use of novel immunotherapy and targeted therapy agents.

5) Management of complications and symptoms induced by chemotherapy, immunotherapy or targeted therapy including nausea, vomiting, hematologic toxicities (e.g., anemia, neutropenia) and others.

ACCREDITATIONThe Medical Educator Consortium is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT HOURS (CME)The Medical Educator Consortium, designates this live activity for a maximum of 15.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NURSING CEUContinuing Education Credit for Nurses will be awarded by the University of Miami Nursing Education Department. A total of 15 CEU’s will be awarded for attendance to all three days of the conference. Participants may attend separately on Friday for 2.1 credit hours, Saturday for 8.4 credit hours, and Sunday 4.5. A certificate of completion will be provided to each participant at the end of the conference. Credit will be entered into CE Broker.

PHARMACY CEUThis activity is approved for a total of 15 contact hours of Continuing Education Credit for Pharmacists and Pharmacy Technicians awarded by the University of Miami Sylvester Comprehensive Cancer Center. Participants must attend all day lectures to receive credit for that day. Partial credits are not available. Where credits are approved on a session-by-session basis, participants must attend each session in its entirety to receive complete credit for the session.. A certificate of completion will be provided to each participant at the end of the conference. Credit will be entered into CE Broker. UMHC/Sylvester is a approved by the Florida Board of Pharmacy as a provider of continuing pharmacy education. “Partial Credit are available”.

FACULTY DISCLOSURE STATEMENTThe Medical Educator Consortium (MEC) adheres to the ACCME Standards for Commercial Support. All persons that will be in a position to control the content of the CME Activity are required to disclose all relevant financial relationships. Faculty disclosure forms outlining this information will be made available to all participants prior to educational activity. MEC has also implemented a mechanism to identify and resolve all conflicts of interest prior to the education activity being delivered to learners. The source of all support from commercial interests will also be disclosed to learners prior to the beginning of the educational activity.

Educational Committee • Distinguished Faculty 13th Annual Miami Cancer Meeting (MCM): “New Horizons in Treating Patients with Cancer: The Saga of Personalized Medicine”

PROGRAM AGENDA

14th Annual Miami Cancer Meeting (MCM): “New “From Chemotherapy to Targeted Therapy,

Immunotherapy and Beyond!”

HOTEL INFORMATION

REGISTRATION FORM

2:20 pm – 4:00 pm Genitourinary Malignancy Session Moderator: Edgardo S. Santos

2:20 pm – 3:00 pm Tyrosine Kinase Inhibitors and Other Pathways in Renal Cell Carcinoma. Primo N. Lara, Jr.

3:00 pm – 3:40 pm Novel Pathways and Genomics in the Management of Prostate Cancer. Alan Koletsky

3:40 pm – 3:50 pm Round Table Discussion and Q & A Session. Speakers: Lara, Koletsky and Santos

3:50 pm – 4:00 pm Coffee Break & Visit Exhibits

4:00 pm – 5:40 pm Hematology Malignancies Session Moderator: Eduardo M. Sotomayor 4:00: pm – 4:30 pm Immunotherapy and Targeted Therapy in Multiple Myeloma. Sergio Giralt

4:30 pm – 5:00 pm Targeted Therapy for B- and T-Cell Non-Hodgkin’s Lymphomas. Eduardo M. Sotomayor

5:00 pm – 5:30 pm High Risk Myelodysplasia and Acute Leukemias. Martin Tallman

5:30 pm – 6:00 pm Round Table Discussion and Q & A Session. Speakers: Giralt, Sotomayor, Tallman

Sunday, January 22, 20177:00 am – 3:10 am Registration &Visit Exhibits

7:40 am – 8:40 am Breakfast & Learn Symposia (non CME)

8:40 am – 9:50 am Gastrointestinal Malignancy Session Moderator: Caio Max Rocha-Lima

8:40 am – 9:10 am Novel Advances in Treatment of Gastric Cancers and Pancreatobiliary Malignancies. Caio Max Rocha Lima

9:10 am – 9:40 am Genomics and New Insights of Colorectal Cancer. Jaffe Ajani

9:40 am – 9:50 am Round Table Discussion and Q & A session Speakers: Ajani and Rocha-Lima

9:50 am – 10:20 am Thyroid Malignancies. Brian Hunis

10:20 am – 10:40 am Coffee Break & Visit Exhibits

10:40 am – 12:40 pm Lung Cancer Session Moderator: Edgardo S. Santos

10:40 am – 11:10 am EGFR, ALK and ROS-1 in Lung Cancer. Luis E. Raez

11:10 am – 11:40 am Other Novel Pathways in Lung Cancer (MET, RET, NTRK, BRAF) and Antiangiogenic Agents. Barbara Gitlitz

11:40 am – 12:10 pm Where are we now in Squamous-NSCLC and Small Cell Lung Cancer? Edgardo S. Santos

12:10 pm – 12:30 pm Round Table Discussion and Q & A Session. Speakers: Gitlitz, Raez & Santos

12:30 pm – 1:40 pm Lunch & Learn Symposia

1:40 pm – 3:15 pm Breast Cancer Section Moderator: Denisse Bretel

1:40 pm – 2:20 pm Anti-HER2 Therapies in Breast Cancer: Adjuvant and Neoadjuvant. Hope Rugo 2:20 pm – 3:00 pm Chemotherapy and Hormonal Therapy in the Metastatic Setting. (non Her2 therapy) Vicente Valero

3:00 pm – 3:10 pm Round Table Discussion and Q & A Session. Speakers: Rugo, Valero, and Bretel

3:10 pm Meeting Adjourn and Closing Remarks

The Conrad Hilton Hotel Miami 1395 Brickell Avenue Miami, FL 33131 Telephone: 305-503-6585 Website: http://conradhotels1.hilton.com

Discover the luxury of the Conrad Miami, the premier hotel in South Florida, com-bining the ultimate hotel service and the latest technological advancements with the fashion sensibilities of downtown Miami. Located in the innovatively designed structure of concave glass and steel, in the heart of the city’s financial district, the Conrad Miami hotel overlooks Biscayne Bay in Florida. The Conrad Miami has quick and easy access to many attractions in downtown Miami, including South Beach, Coconut Grove and Key Biscayne and is also just 15 minutes from the Mi-ami International Airport.

The hotel is offering special rates during this conference of $315 Deluxe City View; $345 Deluxe Bay View plus tax, European plan (no meals). The cut of date to make reservations is January 4, 2017, after this date reservations are subject to hotel availability.

Make your reservations by calling 1-800-CONRADS and identify you as attending the “Miami Cancer Meeting” group code “AMC ” or using the link https://resweb.passkey.com/go/MCM2017

Meetings, Events and Conference Coordinators, Inc.P.O. Box 430376Miami, FL 33243-0376

_____________PRST STD

US Postage PAID

Miami, FLPermit No. 1429

14TH ANNUAL MIAMI CANCER MEETING (MCM):

“From Chemotherapy to Targeted Therapy, Immunotherapy and Beyond!”

January 20-22, 2017Conrad Hilton Hotel

Miami, Florida

PROGRAM AGENDA Continued...

January 20-22, 2017Conrad Hilton Hotel

Miami, Florida

14TH ANNUAL MIAMI CANCER MEETING (MCM): “From Chemotherapy to Targeted Therapy, Immunotherapy and Beyond!”

Fees: $250 - Physicians

$100 - Residents, Fellows,

Nurses & Allied

Health Professionals

$300 - Industry Professionals

Registration fee includes all day admission to the Friday evening, Saturday, and Sunday scientific presentations. Refunds must be provided in writing prior to December 20th, 2016 no Refunds will be provided. Prior to the December 20th deadline any cancella-tion will include a $50 administrative charge. Register online at www.meccinc.com

Register online at www.meccinc.com

CONFERENCE MANAGEMENT MECC (Meetings Events & Conference Coordinators, Inc.)6619 S Dixie Highway #341, Miami, FL 33143Telephone 305/663-1628 Office Fax 305/675-2718

Or visit our website at www.meccinc.com

REGISTRATION

14th Annual Miami Cancer Meeting (MCM): “From Chemotherapy to Targeted Therapy, Immunotherapy and Beyond!”

January 20-22, 2017Conrad Hilton Hotel, Miami, FL

Register online at www.meccinc.com or FAX to 305/675-2718.

Name __________________________________________________________________________ Degree __________________________

Address ___________________________________________________________________________________________________________

City _________________________________________________ State ______________________ Zip _____________________________

Telephone (_____)_____________________________________________ Fax (_____) __________________________________________

Email address _____________________________________________________________________________________________________

Specialty _________________________________________________________________________________________________________

Type of Practice: o Private o Academic o Hospital o Resident/Fellow Registration fee: $ 250 - Physicians $ 100 - Residents, Fellows, Nurses and Allied Health Professionals $ 300 - Industry Professionals

Enclosed is my check in the i/a/o of _____ for registration of this course.I authorize MECC to charge my credit card i/a/o $______ for registration of this course using the following credit card.

Name on Card ________________________________________________________________ Exp. Date ___________________________

Card number _________________________________________________________________ CVV ________________________________

Authorized signer __________________________________________________________________________________________________

If you require special assistance or have specific dietary requirements, please contact MECC, Inc. no later than January 4th, 2017 via email at tvalls@meccinc.com.

Sponsored by:The Medical Educator Consortium

Jumana Ashy, M.S, Pharm.DEileen Butler, RN, MSN. OCN, CPHON, BMTCNGerardo Colon-Otero, MD Dina Dumercy, Pharm.D., BCOP

Primo Lara, M.D.Jessica MacIntrye, ARNP, NP-CEduardo Sotomayor, MD

Educational Committee

Luis E. Raez, M.D, FACP, FCCPChief of Hematology-Oncology & Medical DirectorMemorial Cancer InstituteMemorial Health Care SystemClinical Associate Professor of MedicineHerbert Wertheim College of MedicineFlorida International UniversityMiami, Florida

Caio Max S. Rocha Lima, M.D. Hematology and OncologyAssociate Cancer Center Director for Translational Research Gibbs Cancer Center & Research InstituteCMO Guardian Research Network Spartanburg Healthcare System Spartanburg, SC

Edgardo S. Santos Castillero, M.D., FACPMedical Director of Cancer ResearchThoracic and Head and Neck Cancer ProgramsEugene & Christine Lynn Cancer InstituteAssociate Professor of Clinical Biomedical ScienceCharles E. Schmidt College of MedicineFlorida Atlantic UniversityBoca Raton, FL

Program Directors

Co-Sponsored by:Florida Society of Clinical Oncology

HOTEL INFORMATION

REGISTRATION FORM

2:20 pm – 4:00 pm Genitourinary Malignancy Session Moderator: Edgardo S. Santos

2:20 pm – 3:00 pm Tyrosine Kinase Inhibitors and Other Pathways in Renal Cell Carcinoma. Primo N. Lara, Jr.

3:00 pm – 3:40 pm Novel Pathways and Genomics in the Management of Prostate Cancer. Alan Koletsky

3:40 pm – 3:50 pm Round Table Discussion and Q & A Session. Speakers: Lara, Koletsky and Santos

3:50 pm – 4:00 pm Coffee Break & Visit Exhibits

4:00 pm – 5:40 pm Hematology Malignancies Session Moderator: Eduardo M. Sotomayor 4:00: pm – 4:30 pm Immunotherapy and Targeted Therapy in Multiple Myeloma. Sergio Giralt

4:30 pm – 5:00 pm Targeted Therapy for B- and T-Cell Non-Hodgkin’s Lymphomas. Eduardo M. Sotomayor

5:00 pm – 5:30 pm High Risk Myelodysplasia and Acute Leukemias. Martin Tallman

5:30 pm – 6:00 pm Round Table Discussion and Q & A Session. Speakers: Giralt, Sotomayor, Tallman

Sunday, January 22, 20177:00 am – 3:10 am Registration &Visit Exhibits

7:40 am – 8:40 am Breakfast & Learn Symposia (non CME)

8:40 am – 9:50 am Gastrointestinal Malignancy Session Moderator: Caio Max Rocha-Lima

8:40 am – 9:10 am Novel Advances in Treatment of Gastric Cancers and Pancreatobiliary Malignancies. Caio Max Rocha Lima

9:10 am – 9:40 am Genomics and New Insights of Colorectal Cancer. Jaffe Ajani

9:40 am – 9:50 am Round Table Discussion and Q & A session Speakers: Ajani and Rocha-Lima

9:50 am – 10:20 am Thyroid Malignancies. Brian Hunis

10:20 am – 10:40 am Coffee Break & Visit Exhibits

10:40 am – 12:40 pm Lung Cancer Session Moderator: Edgardo S. Santos

10:40 am – 11:10 am EGFR, ALK and ROS-1 in Lung Cancer. Luis E. Raez

11:10 am – 11:40 am Other Novel Pathways in Lung Cancer (MET, RET, NTRK, BRAF) and Antiangiogenic Agents. Barbara Gitlitz

11:40 am – 12:10 pm Where are we now in Squamous-NSCLC and Small Cell Lung Cancer? Edgardo S. Santos

12:10 pm – 12:30 pm Round Table Discussion and Q & A Session. Speakers: Gitlitz, Raez & Santos

12:30 pm – 1:40 pm Lunch & Learn Symposia

1:40 pm – 3:15 pm Breast Cancer Section Moderator: Denisse Bretel

1:40 pm – 2:20 pm Anti-HER2 Therapies in Breast Cancer: Adjuvant and Neoadjuvant. Hope Rugo 2:20 pm – 3:00 pm Chemotherapy and Hormonal Therapy in the Metastatic Setting. (non Her2 therapy) Vicente Valero

3:00 pm – 3:10 pm Round Table Discussion and Q & A Session. Speakers: Rugo, Valero, and Bretel

3:10 pm Meeting Adjourn and Closing Remarks

The Conrad Hilton Hotel Miami 1395 Brickell Avenue Miami, FL 33131 Telephone: 305-503-6585 Website: http://conradhotels1.hilton.com

Discover the luxury of the Conrad Miami, the premier hotel in South Florida, com-bining the ultimate hotel service and the latest technological advancements with the fashion sensibilities of downtown Miami. Located in the innovatively designed structure of concave glass and steel, in the heart of the city’s financial district, the Conrad Miami hotel overlooks Biscayne Bay in Florida. The Conrad Miami has quick and easy access to many attractions in downtown Miami, including South Beach, Coconut Grove and Key Biscayne and is also just 15 minutes from the Mi-ami International Airport.

The hotel is offering special rates during this conference of $315 Deluxe City View; $345 Deluxe Bay View plus tax, European plan (no meals). The cut of date to make reservations is January 4, 2017, after this date reservations are subject to hotel availability.

Make your reservations by calling 1-800-CONRADS and identify you as attending the “Miami Cancer Meeting” group code “AMC ” or using the link https://resweb.passkey.com/go/MCM2017

Meetings, Events and Conference Coordinators, Inc.P.O. Box 430376Miami, FL 33243-0376

_____________PRST STD

US Postage PAID

Miami, FLPermit No. 1429

14TH ANNUAL MIAMI CANCER MEETING (MCM):

“From Chemotherapy to Targeted Therapy, Immunotherapy and Beyond!”

January 20-22, 2017Conrad Hilton Hotel

Miami, Florida

PROGRAM AGENDA Continued...

January 20-22, 2017Conrad Hilton Hotel

Miami, Florida

14TH ANNUAL MIAMI CANCER MEETING (MCM): “From Chemotherapy to Targeted Therapy, Immunotherapy and Beyond!”

Fees: $250 - Physicians

$100 - Residents, Fellows,

Nurses & Allied

Health Professionals

$300 - Industry Professionals

Registration fee includes all day admission to the Friday evening, Saturday, and Sunday scientific presentations. Refunds must be provided in writing prior to December 20th, 2016 no Refunds will be provided. Prior to the December 20th deadline any cancella-tion will include a $50 administrative charge. Register online at www.meccinc.com

Register online at www.meccinc.com

CONFERENCE MANAGEMENT MECC (Meetings Events & Conference Coordinators, Inc.)6619 S Dixie Highway #341, Miami, FL 33143Telephone 305/663-1628 Office Fax 305/675-2718

Or visit our website at www.meccinc.com

REGISTRATION

14th Annual Miami Cancer Meeting (MCM): “From Chemotherapy to Targeted Therapy, Immunotherapy and Beyond!”

January 20-22, 2017Conrad Hilton Hotel, Miami, FL

Register online at www.meccinc.com or FAX to 305/675-2718.

Name __________________________________________________________________________ Degree __________________________

Address ___________________________________________________________________________________________________________

City _________________________________________________ State ______________________ Zip _____________________________

Telephone (_____)_____________________________________________ Fax (_____) __________________________________________

Email address _____________________________________________________________________________________________________

Specialty _________________________________________________________________________________________________________

Type of Practice: o Private o Academic o Hospital o Resident/Fellow Registration fee: $ 250 - Physicians $ 100 - Residents, Fellows, Nurses and Allied Health Professionals $ 300 - Industry Professionals

Enclosed is my check in the i/a/o of _____ for registration of this course.I authorize MECC to charge my credit card i/a/o $______ for registration of this course using the following credit card.

Name on Card ________________________________________________________________ Exp. Date ___________________________

Card number _________________________________________________________________ CVV ________________________________

Authorized signer __________________________________________________________________________________________________

If you require special assistance or have specific dietary requirements, please contact MECC, Inc. no later than January 4th, 2017 via email at tvalls@meccinc.com.

Sponsored by:The Medical Educator Consortium

Jumana Ashy, M.S, Pharm.DEileen Butler, RN, MSN. OCN, CPHON, BMTCNGerardo Colon-Otero, MD Dina Dumercy, Pharm.D., BCOP

Primo Lara, M.D.Jessica MacIntrye, ARNP, NP-CEduardo Sotomayor, MD

Educational Committee

Luis E. Raez, M.D, FACP, FCCPChief of Hematology-Oncology & Medical DirectorMemorial Cancer InstituteMemorial Health Care SystemClinical Associate Professor of MedicineHerbert Wertheim College of MedicineFlorida International UniversityMiami, Florida

Caio Max S. Rocha Lima, M.D. Hematology and OncologyAssociate Cancer Center Director for Translational Research Gibbs Cancer Center & Research InstituteCMO Guardian Research Network Spartanburg Healthcare System Spartanburg, SC

Edgardo S. Santos Castillero, M.D., FACPMedical Director of Cancer ResearchThoracic and Head and Neck Cancer ProgramsEugene & Christine Lynn Cancer InstituteAssociate Professor of Clinical Biomedical ScienceCharles E. Schmidt College of MedicineFlorida Atlantic UniversityBoca Raton, FL

Program Directors

Co-Sponsored by:Florida Society of Clinical Oncology